GW8510 alleviates muscle atrophy and skeletal muscle dysfunction in mice through AMPK/PGC1α signaling
International Journal of Molecular Medicine · 2025
DOI: 10.3892/ijmm.2025.5569 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Medicine, 2025. Verfasst von Yutong Chen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Peking University International Cancer Institute, School of Basic Medical Sciences, Peking University Health Science Center, Beijing 100191, P.R. Chi…. Hauptthemen laut MEDLINE: Muscular Atrophy, Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha, Muscle, Skeletal, AMP-Activated Protein Kinases. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Preventing and restoring muscle loss and function is essential for elderly individuals. GW8510 may accelerate myotube differentiation. The present study aimed to investigate the protective effect of GW8510 (a CDK2 inhibitor) on muscle atrophy. Mouse models of muscle atrophy were induced by denervation, dexamethasone and glycerol. Muscle‑to‑body weight ratio, the cross‑sectional area of muscles, grip strength, fatigue and serum levels of superoxide dismutase and creatine kinase were assessed. In vitro, a dexamethasone‑induced C2C12 myotube atrophy model was used to evaluate mitochondrial function. Reverse transcription‑quantitative PCR, immunoblotting and small interfering RNA transfection were performed to explore the potential molecular mechanisms following treatment with GW8510. GW8510 resulted in a significant increase in the gastrocnemius and soleus muscle ratios in denervation mice (7 and 3%, respectively), alongside an increase in cross‑sectional area. Moreover, GW8510 significantly improved grip strength and superoxide dismutase activity, with similar protective effects in dexamethasone‑ and glycerol‑induced muscle atrophy models. GW8510 decreased reactive oxygen species production, increased mitochondrial DNA copy number, maintained mitochondrial dynamics and enhanced antioxidant activity in C2C12 myotubes. Mechanistically, GW8510 significantly inhibited the expression of atrophy‑associated markers F‑box protein 32 and tripartite motif‑containing 63 while activating AMPK (both P
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Peking University International Cancer Institute, School of Basic Medical Sciences, Peking University Health Science Center, Beijing 100191, P.R. China.
- Beijing Gigaceuticals Tech. Co. Ltd., Beijing 102206, P.R. China.
Zitieren
APA
Chen, Y., Liu, Z., Liu, C., Yang, D., Xiao, M., Li, Z., & Xie, Z. (2025). GW8510 alleviates muscle atrophy and skeletal muscle dysfunction in mice through AMPK/PGC1α signaling. International Journal of Molecular Medicine. https://doi.org/10.3892/ijmm.2025.5569
Vancouver
Chen Y, Liu Z, Liu C, Yang D, Xiao M, Li Z, et al. GW8510 alleviates muscle atrophy and skeletal muscle dysfunction in mice through AMPK/PGC1α signaling. International Journal of Molecular Medicine. 2025. doi:10.3892/ijmm.2025.5569
BibTeX
@article{Chen2025,
author = {Chen, Yutong and Liu, Zurui and Liu, Chen and Yang, Daqian and Xiao, Mengmeng and Li, Zhengqian and Xie, Zhengwei},
title = {GW8510 alleviates muscle atrophy and skeletal muscle dysfunction in mice through AMPK/PGC1α signaling},
journal = {International Journal of Molecular Medicine},
year = {2025},
doi = {10.3892/ijmm.2025.5569}
}
EUVIMED